2019 annual financial data

Amylyx Pharmaceuticals 2019 Financial results

Direct answer

Revenue was 1,426,000 USD.

Operating income was -13,554,000 USD and net income was -14,816,000 USD.
Operating cash flow was -10,687,000 USD.

Get free Amylyx Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,426,000 USD
Operating income
-13,554,000 USD
Net income
-14,816,000 USD
Operating cash flow
-10,687,000 USD